HAMDT 164 (107th)

An amendment numbered 4 printed in the Congressional Record to prohibit use of funds for approval of new drug applications without disclosure of the cost of research and development of such new drug and what portion of that cost is made up with public funding.

openUnited States· United States Congress· EN

Introduced

—

Last action

—

Status

Mr. Bonilla raised a point of order against the Allen amendment (A032). Mr. Bonilla stated that the amendment sought to change existing law and constituted legislation in an appropriation bill. The Chair sustained the point of order.

Records

Official amendment HAMDT 164 (107th) from United States at United States Congress. Status: Mr. Bonilla raised a point of order against the Allen amendment (A032). Mr. Bonilla stated that the amendment sought to change existing law and constituted legislation in an appropriation bill. The Chair sustained the point of order..

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

amends → Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2002

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/amendment/107th-congress/hamdt-164
Open data entity: https://api.congress.gov/v3/amendment/107/hamdt/164
us · 107-hamdt-164 · source updated 3 February 2022